Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company operates as a chain of pharmacy stores. It offer a range of medicines, including pharmacy products
Hetero Med Solutions Limited, is an unlisted public company incorporated on 15 October, 2007. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 35.00 cr and the total paid-up capital is INR 32.22 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
-3.02%
1.83%
4.82%
-37.33%
-18.59%
4.16
19.26
5.09
2.0
-0.49
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(2)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
MUFG BANK LTD
No. of Loans: 1
Total Amount : 65.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Ramamurty Venkata Bhaskara Yadavalli | 00185783 | 7 years |
| Director | Bandi Vamsikrishna
Shareholder
|
01014619 | 17 years |
| Director | Rammohan Reddy Kura | 07307398 | 1 years |
| Kmp | Kiran Kumar Manikwar | <HIDDEN> | 0 years |
| Director | Ramaseshappa Siva Prasad Panchangam | 09447160 | 1 years |
| CFO | Ramesh Babu Bhandaru | <HIDDEN> | 7 years |
| Kmp | Ch Mani Deep | <HIDDEN> | 0 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| PRESCOT INVESTMENTS PRIVATE LIMITED |
Strike Off
|
2.1 L | 1 | Telangana |
| GVK HYDEL PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Andhra Pradesh |
| HETERO WIND POWER LIMITED |
Active
|
154.0 Cr | 3 | Telangana |
| SVS DRUGS AND PHARMACEUTICALS PVT LTD |
Active
|
4.2 L | 1 | Telangana |
| XIVA HEALLTH CARE PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Telangana |
| SHRI BHRAMARAMBIKAS INDUSTRYS LIMITED |
Amalgamated
|
7.2 Cr | 1 | Telangana |
| ENKITA HOSPITALITY PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| JURALA ORGANIC FARMS AND AGRO INDUSTRIES PRIVATE LIMITED |
Active
|
55.1 Cr | 1 | Telangana |
| ANAIKA PROPERTIES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| HETERO MARBLES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| HETERO BIO CHEMICALS LIMITED |
Strike Off
|
5.0 L | 1 | Telangana |
| HETERO WIND POWER (PENNAR) PRIVATE LIMITED |
Active
|
65.0 Cr | 1 | Telangana |
| HETERO BIOPHARMA LIMITED |
Active
|
150.1 Cr | 1 | Telangana |
| HETERO LIFE SCIENCES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| SRI SAI KARUNA INDUSTRYS LLP |
Active
|
14.5 Cr | 1 | Telangana |
| JURALA ORGANIC FARMS AND AGRO INDUSTRIES LLP |
Converted and Dissolved
|
25.0 L | 1 | Telangana |
| ALLITA FINVEST AND ADVISORS LLP |
Active
|
4.5 L | 1 | Telangana |
| ELIANA INVESTMENTS AND HOLDINGS LLP |
Active
|
4.5 L | 1 | Telangana |
| Krishn Capital Advisors LLP |
Active
|
398.9 Cr | 1 | Telangana |
| TIRTARUPA REALTORS LLP |
Active
|
1.0 L | 1 | Telangana |
| VRINDA LAND VENTURES LLP |
Active
|
10.0 L | 1 | Telangana |
| DAKSHA LAND HOLDINGS LLP |
Active
|
10.0 L | 1 | Telangana |
| HHC PHARMA LLP |
Active
|
10.0 L | 1 | Telangana |
| GENX PHARMA PRIVATE LIMITED |
Active
|
5.5 Cr | 1 | Telangana |
| HETERO DRUGS LIMITED |
Active
|
3.5 Cr | 1 | Telangana |
| HETERO HEALTHCARE LIMITED |
Active
|
2.0 Cr | 2 | Telangana |
| BANDIS INVESTMENTS PRIVATE LIMITED |
Active
|
22.5 L | 1 | Telangana |
| ASPIRO PHARMA LIMITED |
Active
|
254.1 Cr | 2 | Telangana |
| HETERO LABS LIMITED |
Active
|
277.1 Cr | 1 | Telangana |
The incorporation date of HETERO MED SOLUTIONS LIMITED is 15 October, 2007
The authorized share capital of HETERO MED SOLUTIONS LIMITED is INR ₹ 35.0 Cr.
The paid-up capital of HETERO MED SOLUTIONS LIMITED is INR ₹ 32.2 Cr.
The registered address of HETERO MED SOLUTIONS LIMITED is 7-2-A2, INDUSTRIAL ESTATES, SANATHNAGAR, Sanathnagar I E Balanagar Hyderabad Telangana - 500018
The CIN number of HETERO MED SOLUTIONS LIMITED is U40102TG2007PLC055910.
Expand
Delete
Collapse
See
details
It will take sometime. Please come back in 10
minutes
